Events Archives - Page 32 of 128

3 minute read

Gracell Biotechnologies To Present Data Highlighting Preclinical Efficacy Of SMART CART Against Solid Tumors At Society For Immunotherapy Of Cancer 38th Annual Meeting

October 31, 9:13 AM

Novel, proprietary technology designed to strengthen the functionality of CAR-T cells against solid tumors SMART CAR-T cells demonstrated resistance to immunosuppressive tumor microenvironment (TME) and maintained

GRCL

4 minute read

Werewolf Therapeutics To Present Clinical And Preclinical Data At The Society For Immunotherapy Of Cancer’s 38th Annual Meeting

By Benzinga Newsdesk

October 31, 9:11 AM

Interim, first-in-human clinical results from initial monotherapy dose-escalation cohorts in ongoing Phase 1/1b study of WTX-124 including safety and preliminary antitumor activity to be described in poster

HOWL

4 minute read

Lyell Immunopharma Presentations At SITC Highlight New Nonclinical Data On Product Candidates And Innovative Technology To Shorten TIL Manufacturing

By Benzinga Newsdesk

October 31, 9:09 AM

Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, is presenting new nonclinical data at the

LYEL

3 minute read

Summit Therapeutics Announces Ivonescimab’s Novel Mechanism Of Action Highlighting Cooperative Binding To Be Featured In Poster Presentation At SITC 2023

By Benzinga Newsdesk

October 31, 8:11 AM

Potential First-in-Class Tetravalent Bispecific Antibody Demonstrates Enhanced Binding in the Simultaneous Presence of PD-1 & VEGFCooperative Binding of SMT112 Enables Higher Avidity in the Tumor Microenvironment

SMMT

2 minute read

Alpine Immune Sciences To Present New Translational Data On Povetacicept And Acazicolcept In Systemic Lupus Erythematosus At American College Of Rheumatology Convergence 2023

By Benzinga Newsdesk

October 30, 9:15 AM

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present new

ALPN

3 minute read

INmune Bio Inc. Presents Preclinical Data At SITC 2023 Showing INB03 Is An Innate Immune Check Point Inhibitor That Downregulates SIRPα

By Benzinga Newsdesk

October 30, 9:08 AM

SIRP-CD47 is an innate immune checkpoint known as the "don't eat me" signal. INB03 downregulates expression of SIRPα on macrophages promote increased cancer cell death by antibody dependent cellular

INMB

1 minute read

Events
News

Intuitive Machines Announces That In Coordination With SpaceX, Liftoff Of The IM-1 Lunar Mission Is Now Targeted For a Multi-Day Launch Window Which Opens January 12, 2024

By Benzinga Newsdesk

October 27, 5:27 PM

Intuitive Machines, Inc. (NASDAQ:LUNR, LUNRW)))) ("Intuitive Machines") ("Company"), a leading space exploration, infrastructure, and services company, has announced that in coordination with SpaceX, liftoff of the IM-1

LUNR

1 minute read

BioVie Announces Late-Breaking Abstract Presenting Clinical Safety Data From The Company’s Ascites Phase 2 Trial Accepted For Presentation At AASLD – The Liver Meeting 2023

By Benzinga Newsdesk

October 26, 8:19 AM

BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative

BIVI

1 minute read

Bionano Announces Presentation Of OGM Utility Across Key Applications At the American Society Of Human Genetics Annual Meeting

By Benzinga Newsdesk

October 26, 8:13 AM

A sponsored session will feature Dr. Brynn Levy from Columbia University Medical Center, Dr. Roger Stevenson, founder of Greenwood Genetic Center, and Dr. Alex Hastie from Bionano presenting on the utility of optical

BNGO

2 minute read

OPKO Health To Present New Clinical Data On Rayaldee At Kidney Week 2023

By Benzinga Newsdesk

October 25, 5:19 PM

OPKO Health, Inc. (NASDAQ:OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney Week in Philadelphia on Thursday, November

OPK